can be subject to cross-reactivity with structurally related compounds, it is necessary to have a reference method such as gas chromatography-mass spectrometry (GC-MS) to evaluate these methods. The purpose of this study was to develop a sensitive GC-MS procedure that could be used to validate commercially available assays for serum testosterone. Previous GC-MS methods for the analysis of serum testosterone involved rigorous purification procedures combining liquid-liquid extraction, chromatography, and (or) solid-phase extraction [1] [2] [3] [4] . Furuta et al. reported good results for increased serum testosterone concentrations in the 34.7-62.4 nmol/L range with electron impact GC-MS, but did not provide accuracy and precision data in the normal male or female range [4] . Using a simple solid-phase extraction procedure and electron capture negative chemical ionization (ECNCI), Legrand GC-MS conditions. The initial GC temperature was 160 #{176}C (1-mm hold) followed by a temperature program to 280 #{176}C at 20 #{176}C per minute, where it was held for 3 mm. The injection port temperature was 280 #{176}C and the interface oven was 290 #{176}C. The gas chromatograph was equipped with 15 m X 0.32 mm (i. d.) cross-linked dimethyl polysiloxane (DB-l) with a O.2S-j.tm film thickness (J&W Scientific, Folsom, CA) with ultrahigh purity helium (99.999%; Airgas, Radnor, PA) as the carrier gas.
The GC was operated in the splitless mode for the first 0.7 mm and then was switched to a 1:23 split flow. The injection port sweep flow was 1.25 mL/min.
Methane (research grade 4.0, 99.99%; Airgas) was used as the reagent gas for ECNCI at an ionizer pressure of 107 ± 40 Pa, which corresponded to an analyzer pressure of -2 mPa. Perfluorotributylamine was used to optimize ECNCI tuning at m/z 414 and 633. The mass spectrometer is operated in the ECNCI mode, monitoring ions at m/z 535 ± 0.5 and m/z 538 ± 0.5 for testosterone and testosterone-d3, respectively. Dwell times of 0.2 1 s were used for each ion. The instrument hardware averages 105 data points over the 0.21-s time frame and saves this value as one data point. The mass spectrometer outputs this data directly without any further software signal processing. The emission current was 0.3 mA and 70 eV electrons were used. Typical electron multiplier setting was 950 V.
ACS testosterone assay.
The ACS testosterone assay is a fully automated immunoassay that has a 7.5-mm incubation period. The assay only uses 15 ML of sample but has a sample volume requirement of -100 ML. The assay was obtained from the manufacturer and was used according to the FDA-approved procedure on the ACS:180 system. The ACS testosterone assay stores a two-point calibration for 7 days. In this study, the (peaks 3 and 4). The two peaks present for testosterone are the syn and anti isomers formed during the preparation of the oxime. Attempts were made to try to shift the equilibrium to one or the other isomers by performing the reaction at 70 #{176}C, 23 #{176}C, and 4 #{176}C, but no quantitative differences were observed in the ratios of the two peaks. Since the first peak always had a larger signal than the second, it was used for quantitative analysis. The selected-ion monitoring traces obtained from a healthy woman with low concentrations of testosterone (0.80 nmol/L), shown in Fig. 3 , has a signal-tonoise ratio of -25 for the first testosterone peak. Peak number 5 was identified as DHEA on the basis of retention time and mass spectrum. It elutes just before the testosterone peaks and can be seen in the m/z 535 ion channel from both male and female specimens.
As can be seen in these Figures, the derivatization procedure combined with the selectivity of ECNCI provided clean ion chromatograms that contained no interfering substances.
Kvtraction efficiency of GC-MS. The extraction efficiency of

GC-MS was estimated by supplementing
plasma with testosterone at 3.47, 17.3, and 69.3 nmol/L and comparing the peak areas with an unextracted calibrator after subtracting the peak area of a blank plasma from each plasma sample. The estimated extraction efficiencies at these concentrations were 91, 98, and 110%, respectively (n = 4 at each concentration). showing that there was no carryover from a high sample to the next sample.
The GC-MS assay was calibrated each run by supplementing 1 mL of water with a methanolic calibrator of testosterone at 3.47, 17.3, and 34.7 nmol/L. The use of aqueous calibrators was validated by using standard additions to show that when plasmasupplemented calibrators were compared with aqueous calibrators, there was no significant difference (P = 0.14) in the quantification of testosterone.
Accuracy of GC-MS. Accuracy of the method was determined in
both an open and a blind manner. For the open analysis, serum was outside of ±20% of the target value; consequently, 0.69 was chosen as the limit of quantification for GC-MS analysis. Albumin was used for these experiments because it was not possible to obtain human serum devoid of testosterone and because it is a major binding protein for testosterone.
In the second determination of accuracy, samples were submitted for GC-MS analysis from another laboratory in a blind manner. Results of this blind test are shown in Table 1 .
GC-MS
values represent the mean of two determinations. Samples Sl through S8 were prepared by adding testosterone to serum depleted of steroids and is the material used in the master calibration of the ACS testosterone assay. Samples DPC A through F are also prepared by adding testosterone to serum depleted of steroids and is the material used in the calibration of the DPC RIA for testosterone. Samples Cl through C3 are pooled plasma controls used by the ACS testosterone assay; expected concentrations for these controls (Cl-C3) were derived by immunoassay analysis with the ACS testosterone assay.
Precision of GC-MS. The within-run precision was evaluated by
injecting the same sample six times during the same run. The CVat 3.5, 17.3, and 69.3 nmol/L was 4, 1, and 2%, respectively. The total imprecision of the assay was evaluated by analyzing three concentrations of a Bio-Rad commercial serum control once a week over a 6-month period (n = 32). The mean ± SD (CV) in nmol/L for the low, middle, and high control were 3.4 ± 0.3 (9%), 17.8 ± 1.2 (7%), and 39.9 ± 1.8 (4%), respectively. During the evaluation of the ACS testosterone immunoassay, an additional low control near the limit of quantification was analyzed a total of six times on different days for a mean ± SD (CV) of 0.83 ± 0.14 nmol/L (16%).
Sample storage for GC-MS.
Patients' samples that had been stored for 5 months at <-10 #{176}C were reanalyzed to ensure that the testosterone was stable during this time period. Initial * ± 0.500
I/-I I I
Measured/expected, % 8SamplesSl-S8 is the material used in the master calibration of the ACS testosterone assay. 'Samples DPC A-F is the material used in the calibration of the Diagnostic ProductsCorp. RIA for testosterone. SamplesCl-C3 are trilevel ligandcontrols (CibaComingDiagnostics(. n/a, not applicable. 
Interfering substances by GC-MS.
The possibility that other steroids with similar structures and molecular masses would cause an interference in the CC-MS assay was checked by derivatizing and analyzing various steroids listed in Table 2 . As can be seen from this Table, all of the steroids had different retention times and (or) different mass spectra. The compounds with the most structural similarity to testosterone are epitestosterone and DHEA. These steroids had nearly identical mass spectra to testosterone but were baseline separated from testosterone by the CC. In addition, epitestosterone, which had the closest retention time to testosterone, would not be expected in Precision oftheACS testosterone immunoassay.The total imprecision was calculated by analyzing the control material supplied by the manufacturer in duplicate for 13 batches over a 3-week period (n = 26). The means ± SD (CV) for the low, medium, and high controls were 3.8 ± 0.36 (9.5%), 17.5 ± 0.9 (5.4%), and 43.3 ± 2.8 nmollL (6.5%), respectively. Of these, four were above the normal range. Both assays were in agreement for 16 of 22 abnormal specimens.
Comparisan of GC-MS
The six remaining abnormal male specimens were near the borderline of normal values and did not differ by >2.2 nmollL between methodologies. Figure 5 shows the correlation between the ACS testosterone assay and CC-MS for 44 female patients. Linear regression yielded slope = 0.72, intercept = 1.21 nmol/L, and r2 = 0.31.
As can be seen from Fig. 5 , there is a considerable amount of scatter in the data, but an F-test showed that the slope was significantly different from zero (P <0.001).
GC-MS values
were significantly lower than ACS testosterone values (P <0.001, paired t-test) by an average of 0.89 nmol/L. This difference is clinically significant, considering the low normal range for this population, and is probably due to differences in methodology.
CC-MS specifically measures testosterone, and im.mu.noassays may detect structurally related analytes crossreacting with the antibody used.
There were 10 female specimens with abnormally increased testosterone by at least one of the methodologies. For the 10 abnormal female specimens, the two assays were in agreement for only two specimens.
Of the remaining discrepant samples, two were increased by GC-MS and six were increased by ACS. The two discrepant specimens that were increased by GC-MS had testosterone concentrations of 3.5 and 2.8 nmol/L vs 2.3 and 2.2 nmol/L, respectively, as determined by the ACS testosterone assay. Of the six discrepant samples that were increased by ACS, three were very close to the upper normal range (within 0.17 nmol/L) and, given the imprecision of the assay at this concentration, could be considered within the normal range. DPC RIA was performed to determine if a second immunoassay agreed with either ACS or GC-MS.
DPC values were closer to CC-MS concentrations in 23 of 37 specimens but had a large degree of variability and did not agree well with either ACS or GC-MS.
Discussion
The specificity of ECNCI makes it ideally suited for the analysis of biological extracts that contain few electronegative compounds. By forming halogen-containing derivatives, the sensitivity of ECNCI can be exploited to measure concentrations orders of magnitude lower than that obtainable with electron impact or positive chemical ionization [6, 7] . The two common fluorinated derivatives used for the analysis of testosterone are heptafluorobutyric anhydride (HFBA) and pentafluorobenzyl hydroxylamine hydrochloride (PFB). We used HFBA under conditions previously described [1, 3, 4] and with minor changes, always obtaining a mixture of mono-and diderivatized testosterone.
Consequently, we investigated a PFB/trimethylsilyl derivatization and, with slight modifications from the original description [8] , obtained intense peaks at high m/z free from interference.
The ACS testosterone assay is the first commercially available nonradiometric immunoassay to be checked against a reference method such as GC-MS. It offers a significant improvement over other commercially available assays for the analysis of male testosterone concentrations because it eliminates the use of radioactivity.
The automated nature of the procedure requires minimal operator intervention, which allows for the analysis of up to 90 patient samples per hour. During this evaluation of the ACS testosterone assay, we were able to process 100 specimens in an 8-h shift. This low throughput could easily be improved to several hundred samples per day by utilizing the barcode reader and a laboratory information system. Regardless, the ACS testosterone assay offers a considerable time savings as opposed to GC-MS, for which an analyst must spend 5 h "hands on" to process 40 specimens that are then analyzed overnight with an autosampler-equipped GC-MS. Most importantly, the ACS testosterone assay provides excellent accuracy and precision for male specimens.
The six discrepant (between ACS and CC-MS) male samples were borderline normal and would indicate the need for further evaluation regardless of methodology.
